NCT04168073

Brief Summary

This cross-over clinical trial is being conducted to evaluate the difference in urinary messenger RNA (mRNA) biomarkers of mineralocorticoid receptor activation following a low-sodium diet, as compared to a high-sodium diet. The study team will collect urine and blood samples from each participant to study mineralocorticoid receptor-regulated mRNA biomarkers following the consumption of each diet. The study team will instruct the participants to consume 8 days each of high- (300 mmol/day) and low- (10 mmol/day) sodium meals. The order in which the participants will eat the two study diets will be randomly determined. In between the high- and low-sodium diets, the participants will have a wash-out period of 6 days, during which they will be encouraged to consume their usual diet. Participants will be asked to provide the study team with 24-hour urine samples, random urine samples, and blood samples throughout their participation in this clinical trial.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
21

participants targeted

Target at P25-P50 for not_applicable healthy

Timeline
Completed

Started Feb 2020

Typical duration for not_applicable healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 15, 2019

Completed
4 days until next milestone

First Posted

Study publicly available on registry

November 19, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

February 12, 2020

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 8, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 8, 2021

Completed
Last Updated

December 15, 2022

Status Verified

December 1, 2022

Enrollment Period

1.8 years

First QC Date

November 15, 2019

Last Update Submit

December 6, 2022

Conditions

Keywords

low sodium diethigh sodium dietbiomarkeraldosteronemineralocorticoidmineralocorticoid receptor

Outcome Measures

Primary Outcomes (2)

  • Urinary mineralocorticoid receptor-regulated messenger RNA (mRNA) biomarker

    Urinary mRNA biomarkers following consumption of a high-sodium and low-sodium diet will be measured using real-time quantitative polymerase chain reaction (RT-qPCR).

    Day 15 (after first diet period)

  • Urinary mineralocorticoid receptor-regulated mRNA biomarker

    Urinary mRNA biomarkers following consumption of a high-sodium and low-sodium diet will be measured using real-time quantitative polymerase chain reaction (RT-qPCR).

    Day 29 (after second diet period)

Secondary Outcomes (2)

  • Blood pressure

    Day 15 (after first diet period)

  • Blood pressure

    Day 29 (after second diet period)

Study Arms (2)

High sodium diet

EXPERIMENTAL
Other: High-sodium diet 300 mmol sodium/day

Low sodium diet

EXPERIMENTAL
Other: Low-sodium diet 10 mmol sodium/day

Interventions

Day 7 or day 21 high-sodium diet begins for 8 days. Day 15 wash-out begins for 6 days. Pre-made meals for both the high-and low-sodium diet will be provided to each participant by the study team.

High sodium diet

Day 7 or day 21 low-sodium diet begins for 8 days. Day 15 wash-out begins for 6 days. Pre-made meals for both the high-and low-sodium diet will be provided to each participant by the study team.

Low sodium diet

Eligibility Criteria

Age21 Years - 50 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Normotensive, as defined by:
  • Systolic blood pressure (SBP) \< 140 mmHg and diastolic blood pressure (DBP) \< 90 mmHg
  • Never prescribed an antihypertensive medication
  • Willingness to refrain from intense exercise (for example, swimming, biking, running)

You may not qualify if:

  • Hypertension (history of blood pressure ≥ 140/90 mmHg)
  • History of hypertensive urgency, hypertensive crisis, or hospitalizations for hypertension
  • History of chronic kidney disease
  • History of heart failure
  • Current food allergy
  • Pregnancy
  • Known hyperaldosteronism
  • Current mineralocorticoid antagonist use
  • Current treatment for diabetes mellitus
  • Known adrenal insufficiency
  • Current glucocorticoid use
  • Electrolyte abnormality on baseline laboratory assessment
  • Current potassium supplementation
  • Urinary tract infection (UTI)
  • Significant renal insufficiency or any other condition thought by the Principal Investigator to place the participant at increased risk of injury during the clinical trial or compromise the scientific integrity of the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

Location

MeSH Terms

Interventions

Diet, Sodium-Restricted

Intervention Hierarchy (Ancestors)

Diet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • J Brian Byrd, MD, MS

    University of Michigan

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Internal Medicine

Study Record Dates

First Submitted

November 15, 2019

First Posted

November 19, 2019

Study Start

February 12, 2020

Primary Completion

December 8, 2021

Study Completion

December 8, 2021

Last Updated

December 15, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will share

We will de-identify participant information and will share it with a trusted repository, such as National Institutes of Health (NIH) Figshare or The Inter-university Consortium for Political and Social Research (ICPSR). We will de-identify and share data obtained from analyzing urinary mRNA biomarkers and measuring the systolic and diastolic blood pressure following consumption of a high-sodium and low-sodium diet. Additionally, specific lab values that support the validity and quality of the study treatment will be shared in a trusted repository.

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
De-identified data will be deposited into a repository within 1 year of the conclusion of the study.
Access Criteria
No additional access restrictions will be placed on the de-identified data, beyond those required by the repository to access or download the data.

Locations